CytomX Therapeutics Q3 EPS $(0.09) Misses $(0.05) Estimate, Sales $5.963M Miss $11.625M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 95.65 percent. This is a 228.57 percent decrease over earnings of $0.07 per share
CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 95.65 percent. This is a 228.57 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $5.963 million which missed the analyst consensus estimate of $11.625 million by 48.71 percent. This is a 82.16 percent decrease over sales of $33.432 million the same period last year.